A Verrijken Selected Research

A Verrijken Research Topics

4	Non-alcoholic Fatty Liver Disease 03/2021 - 01/2008
4	Overweight 11/2017 - 05/2010
4	Obesity 07/2014 - 01/2008
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2021 - 08/2006
3	Inflammation (Inflammations) 03/2021 - 08/2006
2	Insulin Resistance 02/2011 - 05/2010
1	Fatty Liver 03/2021
1	Type 2 Diabetes Mellitus (MODY) 03/2021
1	Fibrosis (Cirrhosis) 03/2021
1	Glucose Intolerance 11/2017
1	Prediabetic State (Prediabetes) 11/2017
1	Pediatric Obesity 02/2014
1	Body Weight (Weight, Body) 02/2014
1	Alcoholic Fatty Liver 05/2010

4	Glucose (Dextrose)FDA LinkGeneric 11/2017 - 08/2006
2	Insulin (Novolin)FDA Link 02/2011 - 01/2008
2	Triglycerides (Triacylglycerol)IBA 05/2010 - 08/2006
1	SphingolipidsIBA 03/2021
1	Transcription Factors (Transcription Factor)IBA 07/2014
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2014
1	Phospholipases (Phospholipase)IBA 10/2013
1	ApolipoproteinsIBA 10/2013
1	Proteins (Proteins, Gene)FDA Link 10/2013
1	AdiponectinIBA 02/2013
1	Adiponectin ReceptorsIBA 02/2013
1	C-PeptideIBA 02/2011
1	C-Reactive ProteinIBA 05/2010
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2008
1	Antihypertensive Agents (Antihypertensives)IBA 01/2008
1	LipidsIBA 01/2008
1	Plasminogen Activators (Plasminogen Activator)IBA 08/2006
1	CholesterolIBA 08/2006
1	Fibrinogen (Factor I)FDA Link 08/2006
1	Plasminogen Activator Inhibitor 1IBA 08/2006
1	von Willebrand FactorIBA 08/2006
1	HDL CholesterolIBA 08/2006